Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

By Yanchun Peng, Alexander J. Mentzer, Guihai Liu, X. Yao, Z. Yin, D. Dong, W. Dejnirattisai, T. Rostron, P. Supasa, Chang Liu and 56 more. Nature Immunology, 2020

1,140 citations recorded by the source corpus.

Subfields: Infectious Diseases, Neurology

View Paper: https://www.semanticscholar.org/paper/b28f73c7b35293703ab58143b91f3108d250d86f

Citations in the corpus

• Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (2020, neutral): “13 T-cell responses are important in controlling disease in natural infection 8 and therefore generation of a robust cellular immune response is a desirable attribute for a vaccine against SARS-CoV-2.”
• Adaptive immunity to SARS-CoV-2 and COVID-19 (2021, neutral): “Memory SARS-CoV-2 CD8+ T cells have similar expression profiles (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Peng et al., 2020; Sekine et al., 2020; Zuo et al., 2020a).”